- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
CGM: Redefining Type 2 Diabetes Management
A panelist discusses how continuous glucose monitoring (CGM) technology can help overcome therapeutic inertia and key barriers to glycemic control in type 2 diabetes (T2D) patients by providing real-time data that enables earlier interventions, supports treatment optimization, and helps managed care organizations justify broader CGM adoption for newly diagnosed patients.
Video content above is prompted by the following:
- What are the primary barriers to achieving early and consistent glycemic control in T2D patients?
- How can CGM technology help clinicians address therapeutic inertia in diabetes care?
- What role does CGM play in reducing the time patients spend with suboptimal glucose management?
- How can managed care organizations support earlier adoption of CGM in newly diagnosed T2D patients?
Nurse-Led Care Improves Disease Activity in Rheumatoid Arthritis
January 8th 2025Nurse-led care effectively reduces disease activity and improves self-efficacy in patients with rheumatoid arthritis, delivering comparable outcomes to rheumatologist-led care and usual care while easing health care burdens.
Read More
MRD Status Prior to Allo-HSCT Shows Strong Prognostic Value in AML, MDS
January 6th 2025A study demonstrated that pre-transplant measurable residual disease (MRD) status is a strong prognostic factor for overall survival, disease-free survival, and relapse risk in patients with AML and MDS undergoing allogeneic stem cell transplantation.
Read More
